MedAvail Holdings (STU:73M) Stock Based Compensation: €2.02 Mil (TTM As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:73M MedAvail Holdings Inc STU:73M
12 GF Score
Price €11.05
View Full Analysis

What is MedAvail Holdings Stock Based Compensation?

MedAvail Holdings STU:73M 12 Stock Based Compensation is €2.02 Mil as of Jun. 2023. GuruFocus rates STU:73M with a GF Score™ of 12/100.

MedAvail Holdings's Stock Based Compensation for the three months ended in Jun. 2023 was €0.35 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 was €2.02 Mil.

MedAvail Holdings Stock Based Compensation Related Terms

MedAvail Holdings Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for MedAvail Holdings's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedAvail Holdings Stock Based Compensation Chart

MedAvail Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Stock Based Compensation
0.32 0.31 1.07 2.17

MedAvail Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.57 0.52 0.58 0.35
STU:73M
12GF Score
MedAvail Holdings Inc STU:73M
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedAvail Holdings Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.02 Mil.

What does a Stock Based Compensation of €2.02 Mil mean?
MedAvail Holdings (STU:73M) has a Stock Based Compensation of €2.02 Mil as of Jun. 2023. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MedAvail Holdings and its competitors.
Is MedAvail Holdings' Stock Based Compensation too high?
MedAvail Holdings' current Stock Based Compensation is €2.02 Mil. Overall, MedAvail Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does MedAvail Holdings' Stock Based Compensation compare to HEWA and BIMI?
MedAvail Holdings' Stock Based Compensation of €2.02 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for MedAvail Holdings and its competitors. MedAvail Holdings's current Stock Based Compensation is €2.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedAvail Holdings stock overvalued right now?
MedAvail Holdings (STU:73M) has a current Stock Based Compensation of €2.02 Mil. The current Stock Based Compensation is €2.02 Mil. MedAvail Holdings' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For MedAvail Holdings (STU:73M), the current Stock Based Compensation is €2.02 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MedAvail Holdings Business Description

Address 4720 East Cotton Gin Loop, Suite 220, Phoenix, AZ, USA, 85040
MedAvail Holdings Inc is a telehealth-enabled pharmacy technology company. It operates in two segments: Retail Pharmacy Services and Pharmacy Technology. It generates the majority of revenue from the Retail Pharmacy Services segment, which is into operating SpotRx, a full-service retail pharmacy utilizing MedAvail's automated pharmacy technology, servicing Medicare patients in the United States. The Pharmacy Technology segment develops and commercializes the MedCenter for direct sale or lease to third-party customers.
12GF Score

Get the complete analysis for STU:73M

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.05
Price